Alphatec Holdings, Inc. (ATEC)

Market Cap	1.41B
Revenue (ttm)	572.74M
Net Income (ttm)	-177.87M
Shares Out	141.77M
EPS (ttm)	-1.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,331,755
Open	9.60
Previous Close	9.57
Day's Range	9.54 - 10.12
52-Week Range	4.88 - 17.34
Beta	1.31
Analysts	Strong Buy
Price Target	17.82 (+79.46%)
Earnings Date	Oct 30, 2024

About ATEC

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 2, 2006
• Employees: 839
• Stock Exchange: NASDAQ
• Ticker Symbol: ATEC
• Website: https://www.atecspine.com

Financial Performance

In 2023, Alphatec Holdings's revenue was $482.26 million, an increase of 37.45% compared to the previous year's $350.87 million. Losses were -$186.64 million, 23.4% more than in 2022.

Analyst Forecast

According to 11 analysts, the average rating for ATEC stock is "Strong Buy." The 12-month stock price forecast is $17.82, which is an increase of 79.46% from the latest price.

Price Target

$17.82

(79.46% upside)

Analyst Consensus: Strong Buy